[Form 4] Bruker Corporation Insider Trading Activity

Rhea-AI Filing Summary

Bruker Corporation insider grant to its President & CEO. The filing reports that on 08/15/2025 Burkhard Prause, listed as President & CEO, was granted 5,298 Restricted Stock Units (RSUs) and 5,008 stock options with an exercise price of $33.52. The RSUs vest in four equal annual installments beginning on the first anniversary of the 08/15/2025 grant date, and the options vest on the same four-year annual schedule with an exercisable date beginning 08/15/2026 and expiration on 08/15/2035. After the RSU grant the reporting person beneficially owned 25,158 shares. The form is signed by an attorney-in-fact on 08/19/2025.

Positive

• Grant disclosed: 5,298 Restricted Stock Units and 5,008 stock options were clearly reported for 08/15/2025
• Vesting schedule disclosed: RSUs and options vest in equal installments on each of the first four anniversaries of 08/15/2025
• Options terms provided: Exercise price of $33.52, first exercisable 08/15/2026, expiration 08/15/2035
• Post-transaction ownership: Reporting person beneficially owned 25,158 shares following the RSU grant

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine equity-based compensation granted to the CEO with four-year vesting, common for retention and alignment.

The report documents standard executive equity awards: 5,298 RSUs and 5,008 options at a $33.52 strike, each vesting in four equal annual tranches. The options become first exercisable on 08/15/2026 and expire 08/15/2035. Such grants are typical for linking executive pay to company performance over multiple years. The filing provides clear vesting and ownership figures but contains no commentary on grant rationale or performance conditions.

Compensation Analyst

TL;DR: Material details of award size and schedule are disclosed, but no performance metrics are included.

The Form 4 discloses precise quantities and vesting terms: 5,298 RSUs and 5,008 stock options at $33.52, vesting in equal annual installments over four years. The disclosure allows calculation of potential dilution and timing of potential insider sales, but it does not state whether awards are time-based only or tied to specific performance targets.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prause Burkhard

(Last) (First) (Middle)

BRUKER CORPORATION

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRES. & CEO, BRUKER BEST

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		A		5,298(1)	A	$0	25,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$33.52	08/15/2025		A		5,008		08/15/2026(2)	08/15/2035	Common Stock	5,008	$0	5,008	D

Explanation of Responses:

1. The Restricted Stock Units granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

2. The Stock Options granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did BRKR CEO Burkhard Prause receive on 08/15/2025?

The filing shows 5,298 Restricted Stock Units and 5,008 stock options were granted on 08/15/2025.

What is the exercise price and term for the stock options granted to the BRKR CEO?

The options have an exercise price of $33.52, first exercisable 08/15/2026, and expire on 08/15/2035.

How do the RSUs and options vest according to the Form 4?

Both the RSUs and the stock options vest in equal installments on the first, second, third and fourth anniversaries of the 08/15/2025 grant date.

How many shares did the reporting person own after the transaction?

After the reported RSU grant the reporting person beneficially owned 25,158 shares.

When was the Form 4 signed and by whom?

The form is signed by /s/ Michael Simone, Attorney-in-Fact with a signature date of 08/19/2025.